Project 3: Responding to Changing Serological and Viral Information around COVID-19 (RESPOND)

项目 3：应对围绕 COVID-19 不断变化的血清学和病毒信息（RESPOND）

基本信息

批准号：
10688397
负责人：
Ann Scheck McAlearney
金额：
$ 14.16万
依托单位：
OHIO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-18 至 2024-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10688397
关键词：
Address Affect Basic Science Behavioral Bioethics Consultants COVID-19 COVID-19 pandemic COVID-19 risk COVID-19 testing COVID-19 vaccination Caregivers Clinical Collaborations Communication Communication Tools Decision Making Development Diabetes Mellitus Disease Effectiveness Ensure Exposure to Face Family Fright General Population Government Health Health Personnel Health Services Health behavior change Heart Diseases Household Immune system Immunity Individual Infection Internet Interview Knowledge Lung diseases Malignant Neoplasms Measures Methods Mission Modality Organizational Change Outcome Patients Perception Persons Population Provider Public Health Research Research Methodology Resolution Risk Role SARS-CoV-2 exposure SARS-CoV-2 immunity SARS-CoV-2 infection Science Serology Serology test Site Source Stigmatization Surveys Test Result Testing Time Translating Update Vaccination Vaccines Viral Virus Work cancer therapy coronavirus disease cost disease transmission empowered experience first responder follow-up health communication high risk implementation science improved improved outcome infection risk insight news pandemic disease personal protective equipment population health response social media tool transmission process uptake web site

项目摘要

Project Summary Responding to the COVID-19 pandemic requires research to understand how the virus is transmitted, what types of protection are most effective, how immunity is acquired and persists, and how to best encourage people to make use of available testing and vaccines. As our understanding of serologic and viral testing opportunities and implications of test results improves, so too does our ability to provide guidance to individuals at higher risk from exposure, such as first responders and their household contacts, as well as the general public. Communication about the risks related to COVID-19, which is reliable and tailored to the appropriate audience, empowers individuals to make the best decisions to protect themselves. Further, when a vaccine becomes available, a thorough understanding of the barriers and perceptions related to vaccination will be critical for promoting and facilitating uptake. Translating new basic science discoveries quickly and to the appropriate audiences will thus ensure the effectiveness of initiatives that can address the spread of COVID-19. To that end, Project 3, “Responding to Changing Serological and Viral Information around COVID-19 (RESPOND),” seeks to leverage information and discoveries from Projects 1 and 2, as well as from collaborations with other SeroNet Centers and Components, to develop actionable communication tools for organizations and individuals to empower them to utilize the most up-to-date information to guide their decisions. Using a mixed methods approach, including qualitative interviews and surveys in Year 1, we will first develop a baseline understanding of the communication mechanisms used by stakeholder organizations such as government and administrative health agencies, healthcare provider organizations, and employers of individuals at higher risk of exposure and disease transmission. We will also assess baseline understanding of COVID-19 risks and testing options by individuals at higher risk, including first responders and their household contacts, as well as patients undergoing cancer treatment. In Years 2-5, we will continue our mixed methods approach through follow-up interviews and surveys incorporating new information learned Projects 1 and 2, and from SeroNet collaborators. Throughout the study we will disseminate our findings through a project website presenting communication best practices and providing tools we develop for specific stakeholder audiences, as well as the general public.

项目概要应对 COVID-19 大流行需要研究了解病毒的传播方式、病毒类型保护措施最有效、免疫力如何获得和持续、以及如何最好地鼓励人们根据我们对血清学和病毒检测机会的了解，利用现有的检测和疫苗。测试结果的影响得到改善，我们为高风险个体提供指导的能力也得到提高接触者，例如急救人员及其家庭联系人，以及公众。有关与 COVID-19 相关风险的信息，该信息可靠且针对适当受众量身定制，使此外，当疫苗可用时，个人可以做出最好的决定来保护自己。彻底了解与疫苗接种相关的障碍和看法对于促进和预防疫苗接种至关重要因此，将新的基础科学发现快速转化为适当的受众。确保应对 COVID-19 传播的举措的有效性。为此，项目 3“应对围绕 COVID-19 不断变化的血清学和病毒信息” (RESPOND)”旨在利用项目 1 和 2 以及项目的信息和发现与其他 SeroNet 中心和组件合作，开发可操作的通信工具组织和个人使他们能够利用最新的信息来指导他们的决策。使用混合方法，包括第一年的定性访谈和调查，我们将首先制定一个对利益相关者组织使用的沟通机制的基本了解，例如政府和行政卫生机构、医疗保健提供者组织以及个人雇主我们还将评估对 COVID-19 的基本了解。风险和高风险个人（包括急救人员及其家庭接触者）的测试选择，以及接受癌症治疗的患者在第 2-5 年，我们将继续采用混合方法。通过后续访谈和调查，结合从项目 1 和 2 中学到的新信息， SeroNet 合作者在整个研究过程中我们将通过项目网站传播我们的研究结果。展示沟通最佳实践并提供我们为特定利益相关者受众开发的工具，例如以及广大公众。